174 related articles for article (PubMed ID: 4228698)
1. Immunoelectrophoretic characterization of plasma fibrinogen derivatives in patients with pathological plasma proteolysis.
Fisher S; Fletcher AP; Alkjaersig N; Sherry S
J Lab Clin Med; 1967 Dec; 70(6):903-22. PubMed ID: 4228698
[No Abstract] [Full Text] [Related]
2. The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage.
Marder VJ; Shulman NR; Carroll WR
Trans Assoc Am Physicians; 1967; 80():156-67. PubMed ID: 4230117
[No Abstract] [Full Text] [Related]
3. [Technics for the study of the blood coagulation and fibrinolytic system].
Lasch HG; Heene D
Internist (Berl); 1968 Feb; 9(2):42-8. PubMed ID: 4234941
[No Abstract] [Full Text] [Related]
4. [Coagulation disorders after reinjection of concentrated ascitic fluid. Preliminary study].
Buffet C; Conard J; Boulle J; Samama M; Levy VG
Med Chir Dig; 1973; 2(5):275-80. PubMed ID: 4275793
[No Abstract] [Full Text] [Related]
5. [Diagnosis and treatment of intravascular coagulation processes].
Moriau M; Masure R
Nouv Rev Fr Hematol; 1968; 8(1):5-19. PubMed ID: 4232151
[No Abstract] [Full Text] [Related]
6. Properties of fibrinogenolysis and fibrinolysis products in immune assays.
Beller FK; Maki M
Thromb Diath Haemorrh; 1967 Aug; 18(1-2):114-32. PubMed ID: 4229208
[No Abstract] [Full Text] [Related]
7. [Fibrinolytic picture in a retained abortion. Clinical case].
Mateu-Aragones JM
Acta Obstet Ginecol Hisp Lusit; 1968; 16(2):112-31. PubMed ID: 4238368
[No Abstract] [Full Text] [Related]
8. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
Bokarev IN; Butorov VN; Loginov LE
Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
[No Abstract] [Full Text] [Related]
9. Accumulaon of macromolecular particles in the reticuloendothelial system (RES) mediated by platelet aggregation and disaggregation.
Van Aken WG; Vreeken J
Thromb Diath Haemorrh; 1969 Dec; 22(3):496-507. PubMed ID: 5382287
[No Abstract] [Full Text] [Related]
10. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
Thorsen S; Astrup T
Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113
[No Abstract] [Full Text] [Related]
11. [Hemagglutination inhibition (Merskey's test) in consumption coagulopathies. Apropos of 101 patients].
Soria J; Soria C; Yver J; Girard ML; Samama M; Bilski-Pasquier G
Presse Med (1893); 1971 May; 79(22):1003-6. PubMed ID: 5281042
[No Abstract] [Full Text] [Related]
12. [Therapy with fibrinogen].
Egli H
Hamatol Bluttransfus; 1968; 5():20-8. PubMed ID: 4239552
[No Abstract] [Full Text] [Related]
13. Detection of hypercoagulable states with protamine sulphate tests.
Lipinski B
Acta Univ Carol Med Monogr; 1972; 52():185-8. PubMed ID: 4273929
[No Abstract] [Full Text] [Related]
14. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.
Hawiger J; Niewiarowski S; Gurewich V; Thomas DP
J Lab Clin Med; 1970 Jan; 75(1):93-108. PubMed ID: 4243578
[No Abstract] [Full Text] [Related]
15. [Antifibrinolytic agents and extracorporeal circulation].
Gomes OM; Freitas Neto AG; Wolosker M; Langer B; Dubieu WK; Zerbini EJ
Rev Hosp Clin Fac Med Sao Paulo; 1972; 27(5):209-13. PubMed ID: 4538812
[No Abstract] [Full Text] [Related]
16. [Studies on fibrinolysis in equivalents of the Sanarelli-Shwartzman phenomenon in obstetrics. Immunochemical demonstration of derivatives of fibrin(ogen)].
Steichele DF; Herschlein HJ
Thromb Diath Haemorrh; 1967 Dec; 18(3-4):462-74. PubMed ID: 5590239
[No Abstract] [Full Text] [Related]
17. Split products of fibrinogen after prolonged interaction with plasmin.
Niléhn JE
Thromb Diath Haemorrh; 1967 Aug; 18(1-2):89-100. PubMed ID: 4229209
[No Abstract] [Full Text] [Related]
18. Pharmacological enhancement and short-term stimulation of blood fibrinolytic activity.
Laursen B; Gormsen J
Scand J Haematol; 1969; 6(6):402-8. PubMed ID: 5374117
[No Abstract] [Full Text] [Related]
19. [Behavior of human plasmin inhibitors in intravascularly increased fibrinolytic activity].
Fischer M
Thromb Diath Haemorrh; 1970 Jun; 23(3):513-52. PubMed ID: 4247030
[No Abstract] [Full Text] [Related]
20. Effects on the human fibrinolytic system of prolonged intravenous infusion of high doses of Complamin (xantinol nicotinate).
Bouvier CA; Berthoud S
Helv Med Acta; 1968 Mar; 34(2):170-86. PubMed ID: 4232105
[No Abstract] [Full Text] [Related]
[Next] [New Search]
